Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Technetium × Thoracic × Clear all

Phase

Status

Sponsor Class

OTHER 1 NIH 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphatic Metastasis 1 Lung Neoplasms 1

Interventions

Carboplatin 534 Pemetrexed 388 pembrolizumab 367 Cisplatin 353 Paclitaxel 284 Docetaxel 237 Gemcitabine 167 Nivolumab 156 Erlotinib Hydrochloride 147 Bevacizumab 113 atezolizumab 104 osimertinib 97 durvalumab 91 Etoposide 89 Gefitinib 68 130-nm albumin-bound paclitaxel 65 Cetuximab 61 Ipilimumab 59 Drug Therapy 51 Topotecan 48 Injections 42 Afatinib 41 tislelizumab 40 Cyclophosphamide 38 Vinorelbine 36 Albumin-Bound Paclitaxel 36 Crizotinib 34 cemiplimab 31 icotinib 26 Radiotherapy 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04233476 2024-07-01

TRIIL

RDO Pharm.

Phase 3 Completed

Lung Neoplasms, Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡